Chalk up one more biotech start­up for MIT’s Bob Langer

Bob Langer has an­oth­er biotech start­up to add to his lengthy ros­ter.

Lyn­dra has gath­ered $23 mil­lion to­geth­er to work on a new de­liv­ery tech plat­form de­vel­oped by Langer, Gio­van­ni Tra­ver­so and An­drew Bellinger at MIT.

Lyn­dra’s big idea is that it can de­vel­op plat­form tech that can pro­vide “ul­tra” long act­ing sus­tained re­lease of oral drugs. And it says this new ap­proach could al­so re­duce the side ef­fects as­so­ci­at­ed with some drugs while vast­ly im­prov­ing com­pli­ance. Po­laris part­ner and co-founder Amy Schul­man is lead­ing the ef­fort.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.